LADENBURG THALMANN FINANCIAL SERVICES INC. - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 50 filers reported holding NEOS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$1,0000.0%5200.0%0.00%
Q3 2019$1,0000.0%5200.0%0.00%
Q2 2019$1,0000.0%5200.0%0.00%
Q1 2019$1,0000.0%5200.0%0.00%
Q4 2018$1,000
-66.7%
5200.0%0.00%
Q3 2018$3,000
-25.0%
520
-7.5%
0.00%
Q2 2018$4,0000.0%5620.0%0.00%
Q1 2018$4,000
-20.0%
562
+8.1%
0.00%
Q4 2017$5,000
-50.0%
520
-66.2%
0.00%
Q3 2016$10,000
-28.6%
1,5370.0%0.00%
Q2 2016$14,000
-17.6%
1,5370.0%0.00%
Q1 2016$17,0001,5370.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,971,014$6,413,0004.42%
SPHERA FUNDS MANAGEMENT LTD. 3,711,454$4,788,0000.66%
Proxima Capital Management, LLC 206,000$266,0000.36%
Nantahala Capital Management 4,610,000$5,947,0000.18%
Alambic Investment Management, L.P. 219,090$283,0000.18%
Wealthstar Advisors, LLC 73,295$95,0000.06%
ALGERT GLOBAL LLC 77,845$100,0000.04%
Western Standard LLC 25,935$33,0000.02%
Allred Capital Management, LLC 24,995$33,0000.02%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 320,993$414,0000.02%
View complete list of NEOS THERAPEUTICS INC shareholders